Nacka, Sweden

Tove Eriksson

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Stockholm, SE (2011)
  • Nacka, SE (2012 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tove Eriksson

Introduction

Tove Eriksson, a talented inventor based in Nacka, Sweden, has made significant strides in the field of biotechnology. With a total of five patents to her name, she has demonstrated a strong commitment to advancing medical science and improving healthcare outcomes through innovation.

Latest Patents

Among her latest inventions are two notable patents related to polypeptides. These polypeptides are designed to bind to epidermal growth factor receptor (EGFR) family receptors, showcasing potential applications in medicine, veterinary medicine, diagnosis, diagnostics, and imaging. This cutting-edge work signifies a remarkable advancement in targeted therapy and diagnostic tools.

Career Highlights

Tove currently works at Affibody AB, a prominent company focused on the development of innovative biopharmaceuticals. Her work at Affibody has allowed her to translate her inventive ideas into practical applications, contributing to the company’s mission of improving patient health through novel therapeutic solutions.

Collaborations

Throughout her career, Tove has collaborated with esteemed colleagues, including Andreas Jonsson and Fredrik Nilsson. These partnerships have not only enriched her work but have also fostered a collaborative environment, essential for research and development in the rapidly evolving field of biotechnology.

Conclusion

Tove Eriksson stands out as an inspiring figure in the world of innovation. With her impressive portfolio of patents and her dedication to improving healthcare, Tove exemplifies the potential of inventors in shaping the future of medical science. Her contributions are poised to make a lasting impact on both diagnostic and therapeutic practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…